Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report 2022 – Market Forecast, Trends And Strategies
11 Feb, 2022
The global isothermal nucleic acid amplification technology (INAAT) market size is expected to grow from $2.91 billion in 2021 to $3.20 billion in 2022 at a compound annual growth rate (CAGR) of 10.1%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The INAAT market is expected to reach $4.76 billion in 2026 at a CAGR of 10.4%.
What is the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market?
The isothermal nucleic acid amplification technology market consists of sales of isothermal nucleic acid amplification technologies and related services. The services include only installation and maintenance services offered by equipment manufacturers. Isothermal nucleic acid amplification technologies are used to amplify DNA sequence from two different nucleic acids segments at the constant temperature.
Get a Sample of the global isothermal nucleic acid amplification technology (INAAT) market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=2505&&type=smp
What drives the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market?
The incidence of infectious diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are increasing and require isothermal nucleic acid amplification technology (INAAT) to diagnose them. For instance, according to World Health Organization 17 million people lose their lives to infectious diseases every year. Another report by Centers for Disease Control show that number of diseases from mosquitoes, ticks and fleas like West Nile, Zika, Malaria and Lyme disease increased three times. Similarly, as per a survey done by NCBI, around 50% of the population in the United States (approx. 157 million) was suffering from at least one chronic disease in 2020. Increase in infectious or chronic disease drives the demand for diagnosing through isothermal nucleic acid amplification technology.
Get the full global isothermal nucleic acid amplification technology (INAAT) industry report here:
https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-reportGlobal Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segments
The global isothermal nucleic acid amplification technology (INAAT) market is segmented:
By Product: Instrument, Reagent
By End-User: Hospital, Reference Laboratories, Others
By Technology: NASBA, HAD
By Application: Blood Screening, Infectious Disease Diagnostics, Cancer
By Geography: The regions covered in the isothermal nucleic acid amplification technology (INAAT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2022provides market size and growth forecasts for the global isothermal nucleic acid amplification technology market, global INAAT market share, isothermal nucleic acid amplification technology market segments and geographies, INAAT market competitive landscape including leading competitors’ revenues, profiles and market shares. The isothermal nucleic acid amplification technology market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Playersinclude Alere, Biomeriux, Qiagen, Becton, Dickinson & Company, Hologica, Lucigen, Quidel Corporation, New England Biolabs, Nugen, Ustar Biotechnologies, Thermo Fisher Scientific, BioHelix, Meridian Bioscience, New England Biolabs Inc., Novartis Diagnostics, Sharp Corp, Sony Corp, Panasonic, Toshiba Corp, Rohm, PhilipsHologic-Gen-Probe, BetaLED, Avago technologies, and Grifols. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.